Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.
- DOI
- 10.1016/s2468-1253(26)00119-6
- Published
- 2026 Sep
- Container
- The lancet. Gastroenterology & hepatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2468-1253-26-00119-6,
title = {Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.},
author = {Jairath V and Kierkuś J and Duvall GA and Danese S and Sands BE and Ratiu-Duma B and Singh R and Levine P and Barkay H and Gross N and Abrams K and Reinisch W},
year = {2026},
journal = {The lancet. Gastroenterology \& hepatology},
doi = {10.1016/s2468-1253(26)00119-6},
url = {https://doi.org/10.1016/s2468-1253(26)00119-6}
}RIS
TY - JOUR TI - Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial. AU - Jairath V AU - Kierkuś J AU - Duvall GA AU - Danese S AU - Sands BE AU - Ratiu-Duma B AU - Singh R AU - Levine P AU - Barkay H AU - Gross N AU - Abrams K AU - Reinisch W PY - 2026 JO - The lancet. Gastroenterology & hepatology DO - 10.1016/s2468-1253(26)00119-6 UR - https://doi.org/10.1016/s2468-1253(26)00119-6 ER -
APA
V, J., J, K., GA, D., S, D., BE, S., B, R., R, S., P, L., H, B., N, G., K, A., & W, R. (2026). Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(26)00119-6
Source records
- pubmed · retrieved 2026-09-26T18:24:20.387Z